Advisers to the Food and Drug Administration are meeting to review a gene therapy technique called CRISPR to treat sickle cell disease.

Share:
More In Science
FDA Updates Ozempic Label
The Food and Drug Administration updated the labeling for Ozempic acknowledging reports of blocked intestines for those that use the medication.
Load More